{"nct_id":"NCT06120140","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-02-16","start_date_type":"ACTUAL","primary_completion_date":"2027-05-31","primary_completion_date_type":"ESTIMATED","completion_date":"2032-01-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}